Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herpes Zoster Subunit Vaccine in Systemic Lupus Erythematosus
NCT05559671Phase 4Recruiting
- Sponsor
- NYU Langone Health
- Start
- Dec 2023
- Primary completion
- Feb 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by NYU Langone Health. Started Dec 2023; status: recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05559671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05559671.